Can MRI Tell if a Liver Lesion Is Cancerous or Benign?

Yes, it is entirely possible that a “spot” or lesion found on your liver is a benign (non-cancerous) tumor. When a spot is found on an ultrasound or standard scan, doctors often use specialized imaging—like a dynamic contrast-enhanced MRI or CT scan—to watch how blood flows in and out of the lesion ^[1]. Because different types of liver tumors have different blood supply patterns, tracking this flow can often characterize the lesion without needing a biopsy ^[2].

However, the meaning of any scan heavily depends on your individual risk factors. The same imaging pattern can mean different things depending on whether you have a healthy liver, cirrhosis, or chronic hepatitis B ^[1][3].

How Dynamic MRI Tracks Blood Flow

A dynamic MRI or CT scan works by taking multiple pictures of your liver in rapid succession after a contrast agent is injected into your vein ^[1]. The scan captures different “phases” of blood flow:

• Arterial phase: When the contrast first rushes into the liver through the arteries.
• Portal venous phase: When the contrast flows through the main veins of the liver.
• Delayed phase: When using a standard (extracellular) contrast agent, this phase captures how the contrast distributes and washes out over several minutes.

Some MRI scans use a special hepatobiliary contrast agent (like gadoxetate). These scans include a later “hepatobiliary phase” where normal, healthy liver cells actively absorb and hold onto the contrast, which provides additional clues about the nature of a tumor ^[4].

Common Benign Liver Lesions

When reviewing your scans, your care team looks for patterns that suggest these common benign lesions. While hemangiomas and FNH are generally low-risk, adenomas require more careful evaluation:

• Hepatic Hemangioma: This is a common, low-risk tangle of abnormal blood vessels. On an MRI, a classic hemangioma looks very bright on certain images (T2-weighted images) ^[5]. When the contrast is injected, it typically lights up on the outer edges first and slowly fills into the center over time—a pattern called “progressive centripetal fill-in” ^[6].
• Focal Nodular Hyperplasia (FNH): FNH is a benign cluster of normal-acting liver cells growing around an abnormal blood vessel. It usually enhances uniformly and quickly during the arterial phase ^[7]. A classic clue for FNH is a “central scar,” though not all FNH lesions have one ^[8]. If a hepatobiliary MRI contrast is used, FNH typically absorbs the contrast and remains bright or matches the surrounding liver ^[9].
• Hepatic Adenoma: This is a rarer benign tumor sometimes linked to oral contraceptive or anabolic steroid use ^[10]. Unlike hemangiomas and FNH, adenomas carry risks: some subtypes can cause internal bleeding, and some have a risk of becoming malignant over time ^[11]. Most adenomas will appear dark (hypointense) on the hepatobiliary phase ^[12], but their appearance can vary widely depending on their subtype, making them sometimes difficult to distinguish from FNH or cancer ^[13].

The Classic HCC Pattern

Hepatocellular carcinoma (HCC) behaves differently. In patients at high risk for liver cancer (such as those with cirrhosis or chronic hepatitis B), radiologists use a standardized system called LI-RADS to grade lesions based on their size and specific features ^[2]. The classic HCC pattern includes:

1. Non-rim Arterial Phase Hyperenhancement (APHE): The tumor enhances (lights up) very brightly and quickly when the contrast first enters the arteries ^[14].
2. Nonperipheral Washout: In the later venous or delayed phases, the tumor appears relatively darker than the surrounding healthy liver tissue. This relative difference is called “washout” ^[15].
3. Enhancing Capsule: A distinct, bright rim may be seen around the tumor in later phases ^[16].

If you are in a defined high-risk group and your lesion meets the strict criteria for a LI-RADS 5 (LR-5) category, it is considered definitely HCC ^[2]. In these specific cases, a biopsy is typically not required to confirm the diagnosis, allowing the multidisciplinary care team to begin planning treatment based on the cancer’s stage and your overall liver function ^[17].

When Imaging is Unclear

While these patterns are highly useful, imaging is not always definitive. For example, small hemangiomas can sometimes show a false “pseudo-washout” on hepatobiliary MRI scans ^[18]. Additionally, a significant percentage of HCC tumors have atypical features that do not perfectly match the classic pattern, depending on the tumor’s size and the patient’s population ^[19].

If your scan results are indeterminate, your care team will not guess. They may recommend:

• Multidisciplinary Review: A tumor board consisting of radiologists, hepatologists, surgeons, and oncologists may review your case together.
• Repeat or Alternative Imaging: You may need a follow-up scan in a specific timeframe to check for growth, or a scan using a different type of contrast agent.
• Biopsy: While a biopsy can provide a tissue diagnosis, it is an invasive procedure with risks (such as bleeding) and can sometimes miss the cancerous cells (sampling error) ^[20].

The decision of what to do next is highly individualized, and you should discuss the specific risks and benefits of each option with your care team.